TIGLY

Tigecycline 50mg Injection

A glycylcycline antibiotic effective against severe multidrug-resistant infections, including MRSA and VRE.


  • Class
  • Dosage
  • Indications
  • Mechanism of action

Glycylcycline antibiotic

200-400 mg/day as a single dose or in 2 divided doses.

Tigecycline 50mg Injection can be used in the treatment of the following conditions:

  • Complicated intra-abdominal infections.
  • Complicated skin and soft tissue infections.
  • Community-acquired pneumonia.
  • Multidrug-resistant bacterial infections.
  • Hospital-acquired infections.

Tigecycline binds to the 30S ribosomal subunit, halting bacterial protein synthesis and preventing replication.

Copyright by Neiss Labs Ltd 2025. All rights reserved.